Our Co-Founder and CTO @dasongle is speaking at the AI for Drug Discovery Bridging the Translation Gap workshop at #NeurIPS2026 in Sydney.
Catch his session on Dec 11 on world models for biology and building stateful virtual cell simulators.

ALT The image features a presentation slide titled "AI for Drug Discovery Bridging the Translation Gap." The speaker is on a stage with a microphone and screen, wearing glasses and speaking into a headset. The slide mentions "NeurIPS 2026" and "GenBio" and identifies the speaker as "Le Song, Co-Founder and CTO, GenBio AI." The event details include December 11, 2026, in Sydney, AUS, with a label indicating "Panel Speaker.
6
252
Replying to @nytimes
@nytimes covered @genbioai and its #VirtualCell work today, following a great conversation with the brilliant @carlzimmer! While companies like Isomorphic claim to "cure all diseases" with a drug design engine, we focus on "simulating diseases" for Virtual Trial of Drugs or Other Therapeutics, as well as for biological research, via virtual cell, virtual tissue, and eventually AI-driven digital organism (#AIDO). It is perhaps less ambitious, but in my opinion more realistic and accessible. We have a great team that includes luminaries like David Baker, @Prof_Lundberg, @zivbj, @deboramarks, @segal_eran, @dasongle, and many more superb engineers and researchers. Come join us!
nytimes.com/2026/11/18/scien…
AIDO Cell simulated every layer of this HepG2 cell, from gene expression to cell shape, in one model. Outputs are delivered through the API and explorable in AIDO Lab.
Want to run your own experiments? Join the waitlist: genbio.ai/waitlist/
AIDO Cell simulated every layer of this HepG2 cell, from gene expression to cell shape, in one model. Outputs are delivered through the API and explorable in AIDO Lab.
Want to run your own experiments? Join the waitlist: genbio.ai/waitlist/
Asked by @AlAinNews whether a virtual cell could replace clinical trials, CTO @dasongle said the better word is reduce. AIDO Cell is there to help researchers run fewer experiments and pick the right ones. The interview, in Arabic: bit.ly/4zyFwCF
Asked by @AlAinNews whether a virtual cell could replace clinical trials, CTO @dasongle said the better word is reduce. AIDO Cell is there to help researchers run fewer experiments and pick the right ones. The interview, in Arabic: bit.ly/4zyFwCF
The ADIA Lab Symposium opens in Abu Dhabi on Monday, October 26. @dasongle will be delivering a keynote on day two.
@adia_lab is an independent research institute working in data and computational sciences, and this is its flagship event. Le's talk is AIDO Cell: A General-Purpose Simulator for Cell Biology.
Drugs that fail in clinical trials most often fail on efficacy or unexpected toxicity. In @Forbes, our CTO @dasongle traces both to one gap: no tool can yet predict how a molecule behaves inside a living cell. That gap is what AIDO Cell is for. bit.ly/3VjUoGn
We discussed fundamental issues in the definition, model architecture, computational algorithm, and meaningful evaluation/qualification of a fully steerable virtual cell that is multi-modal, multi-scale, dynamic, and stateful.
@dasongle , @genbioai , @mbzuai , @CarnegieMellon
cell.com/cell/fulltext/S0092…
Out today in @cellpressnews: "A world model of the virtual cell," from our co-founders @ericxing and @dasongle.
Their definition of a virtual cell is a stateful, multi-modal, multi-scale simulator, judged on whether it stays coherent across a sequence of interventions.
Open access: cell.com/cell/fulltext/S0092…
A model that makes one prediction and resets only captures a snapshot. AIDO Cell holds the cell's state: perturb it, read it out, then further experiment on the cell you just changed.
@DrugDiscovNews on where the virtual cell came from, what's left to prove and how world models are redefining cellular simulation: drugdiscoverynews.com/what-i…
More coverage from @fwpharma, @TLDRnewsletter, @BigDATAwireNews, The Innermost Loop (by @alexwg), and other prominent newsletters across AI and biotech.
1
1,623
Join the waitlist for early access: genbio.ai/waitlist/
1
1,465
GenBio AI retweeted
Replying to @genbioai
@genbioai has released a preview of AIDO Cell—a stateful, multiscale world model designed to simulate cellular responses from DNA and RNA through proteins to whole-cell behavior. Early access for researchers is planned.
businesswire.com/news/home/2…
Subscribe to our newsletter and get the biggest biotech news straight to your inbox 🧬
syntheticbiologysummit.com/?…











